Literature DB >> 25065718

Intact IL-12 signaling is necessary for the generation of human natural killer cells with enhanced effector function after restimulation.

Venkateswara R Simhadri1, John L Mariano1, Olatz Zenarruzabeitia2, Christine M Seroogy3, Steven M Holland4, Hye Sun Kuehn5, Sergio D Rosenzweig6, Francisco Borrego7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25065718      PMCID： PMC4252978          DOI： 10.1016/j.jaci.2014.06.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

2.  Cytokine-induced memory-like natural killer cells.

Authors:  Megan A Cooper; Julie M Elliott; Peter A Keyel; Liping Yang; Javier A Carrero; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

Review 3.  Natural killer cell memory.

Authors:  Silke Paust; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

4.  Cytokine activation induces human memory-like NK cells.

Authors:  Rizwan Romee; Stephanie E Schneider; Jeffrey W Leong; Julie M Chase; Catherine R Keppel; Ryan P Sullivan; Megan A Cooper; Todd A Fehniger
Journal:  Blood       Date:  2012-09-14       Impact factor: 22.113

5.  A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo.

Authors:  Sophie Guia; Céline Cognet; Ludovic de Beaucoudrey; Marlowe S Tessmer; Emmanuelle Jouanguy; Claire Berger; Orchidée Filipe-Santos; Jacqueline Feinberg; Yildiz Camcioglu; Jacob Levy; Suliman Al Jumaah; Sami Al-Hajjar; Jean-Louis Stephan; Claire Fieschi; Laurent Abel; Laurent Brossay; Jean-Laurent Casanova; Eric Vivier
Journal:  Blood       Date:  2008-03-04       Impact factor: 22.113

6.  Atypical presentation of IL-12 receptor beta1 deficiency with pneumococcal sepsis and disseminated nontuberculous mycobacterial infection in a 19-month-old girl born to nonconsanguineous US residents.

Authors:  David A Gruenberg; Stephanie Añover-Sombke; James E Gern; Steven M Holland; Sergio D Rosenzweig; Troy R Torgerson; Christine M Seroogy
Journal:  J Allergy Clin Immunol       Date:  2009-11-11       Impact factor: 10.793

7.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

8.  Proinflammatory cytokine signaling required for the generation of natural killer cell memory.

Authors:  Joseph C Sun; Sharline Madera; Natalie A Bezman; Joshua N Beilke; Mark H Kaplan; Lewis L Lanier
Journal:  J Exp Med       Date:  2012-04-09       Impact factor: 14.307

9.  Adaptive immune features of natural killer cells.

Authors:  Joseph C Sun; Joshua N Beilke; Lewis L Lanier
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

10.  Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.

Authors:  Jing Ni; Matthias Miller; Ana Stojanovic; Natalio Garbi; Adelheid Cerwenka
Journal:  J Exp Med       Date:  2012-12-03       Impact factor: 14.307
  10 in total
  8 in total

Review 1.  Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications.

Authors:  Iñigo Terrén; Ane Orrantia; Gabirel Astarloa-Pando; Ainhoa Amarilla-Irusta; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

2.  Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection.

Authors:  Tsukasa Nabekura; Zhiying Chen; Casey Schroeder; Taeju Park; Eric Vivier; Lewis L Lanier; Dongfang Liu
Journal:  J Immunol       Date:  2018-04-04       Impact factor: 5.422

Review 3.  NK Cell-Based Immunotherapy in Renal Cell Carcinoma.

Authors:  Iñigo Terrén; Ane Orrantia; Idoia Mikelez-Alonso; Joana Vitallé; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

Review 4.  Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells.

Authors:  Fei Gao; Zhengwei Zhou; Ying Lin; Guang Shu; Gang Yin; Tianxiang Zhang
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 8.786

5.  A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells.

Authors:  Venkateswara R Simhadri; Milena Dimitrova; John L Mariano; Olatz Zenarruzabeitia; Weimin Zhong; Tatsuhiko Ozawa; Atsushi Muraguchi; Hiroyuki Kishi; Maryna C Eichelberger; Francisco Borrego
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

6.  Mica Nanoparticle, STB-HO Eliminates the Human Breast Carcinoma Cells by Regulating the Interaction of Tumor with its Immune Microenvironment.

Authors:  Tae-Wook Kang; Hyung-Sik Kim; Byung-Chul Lee; Tae-Hoon Shin; Soon Won Choi; Yoon-Jin Kim; Hwa-Yong Lee; Yeon-Kwon Jung; Kwang-Won Seo; Kyung-Sun Kang
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

Review 7.  NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection.

Authors:  Obinna Chijioke; Vanessa Landtwing; Christian Münz
Journal:  Front Immunol       Date:  2016-08-29       Impact factor: 7.561

8.  Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells.

Authors:  Iñigo Terrén; Idoia Mikelez; Irati Odriozola; Andrea Gredilla; Javier González; Ane Orrantia; Joana Vitallé; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.